Emyria Revenue Triples As Sydney Clinic Opens And US Strategy Advances
EMD: $0.039 -4.88% · MC: $31M
Emyria reported record quarterly revenue of approximately $1 million, up from approximately $0.5 million in the same quarter last year, and opened its first Sydney clinic, expanding its network to four states with capacity for up to 90 dosing sessions a week. It received initial Department of Veterans’ Affairs patient approvals, with more than 40 referrals in its pipeline, and appointed former US Veterans Affairs Secretary Dr David Shulkin as a strategic adviser to support US opportunities. The company also said it is in late-stage discussions with an international pharmaceutical sponsor, but no agreement has been finalised.

Comments